For Immediate Release
Contact: Edward Rauen; email@example.com; 513.956.4110
OMNICARE CONTRIBUTES $100,000 TO SUPPPORT NATIONAL MS SOCIETY’S
“NOW” MS RESEARCH CAMPAIGN
Cincinnati, Ohio, August 6, 2015 — With its contribution of $100,000, Omnicare has joined a distinguished group of donors who have partnered with the National Multiple Sclerosis Society to support the Society’s groundbreaking No Opportunity Wasted (NOW) campaign which will raise $250 million to accelerate vital progress towards stopping MS in its tracks, restoring function that has been lost and ending MS forever.
The Omnicare funds will be evenly split between advancing research in three priority areas – Progressive MS, Nervous System Repair, Wellness & Lifestyle – and providing MS Fellowships that help to build future care for people living with MS through a full spectrum of research and clinical training programs for promising scientists and physicians. The latter program has recruited more than 800 new MS field researchers to date.
The NOW campaign, which began in 2010, has been an MS research revolution in driving solutions and providing opportunities for people with MS to live their best lives and is the largest endeavor of its kind. As the NOW campaign draws to its successful close in 2015, it has already resulted in the Society launching 732 new research projects.
“People with MS look to the Society to provide solutions and to provide hope,” said Edward Rauen, Chapter President, National MS Society Ohio Valley Chapter, “ Omnicare’s generous donation helps us not only achieve our NOW research campaign funding goal, but also helps to build a future of pioneering scientific discovery and compassionate care for all those impacted by MS.”
“Omnicare has great empathy for the millions of people affected by multiple sclerosis worldwide,” said Nitin Sahney, Omnicare’s President and Chief Executive Officer. “We are very proud to participate with the National MS Society in advancing research and identifying solutions to help people live their best, most independent lives possible.”
The Society and Omnicare look forward to continuing their partnership as we move forward to creating a world free of MS.
About Multiple Sclerosis
Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million worldwide.
About the National Multiple Sclerosis Society
The Society mobilizes people and resources to drive research for a cure and to address the challenges of everyone affected by MS. To fulfill this mission, the Society funds cutting-edge research, drives change through advocacy, facilitates professional education, collaborates with MS organizations around the world, and provides programs and services designed to help people with MS and their families move their lives forward. In 2014 alone, through our comprehensive nationwide network of programs and services, the Society devoted $122.2 million to assist more than one million individuals to connect to the people, information and resources they needed. To move us closer to a world free of MS, the Society also invested $50.2 million to support more than 380 new and ongoing research projects around the world. The Society is dedicated to achieving a world free of MS. Learn more about MS and the NOW campaign at: www.nationalMSsociety.org.
Omnicare, Inc., a Fortune 500 company based in Cincinnati, Ohio, provides comprehensive pharmaceutical services to patients and providers across the United States. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care institutions, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry’s most innovative technological capabilities to the benefit of its long-term care customers. Omnicare also provides specialty pharmacy and key commercialization services for the bio-pharmaceutical industry through its Specialty Care Group. For more information, visit www.omnicare.com.